Zortrax S.A. (WSE:ZRX)
0.0792
-0.0006 (-0.75%)
At close: Jan 19, 2026
Zortrax Revenue
Zortrax had revenue of 512.08K PLN in the quarter ending September 30, 2025, a decrease of -68.08%. This brings the company's revenue in the last twelve months to 9.06M, down -51.99% year-over-year. In the year 2023, Zortrax had annual revenue of 15.04M, down -62.55%.
Revenue (ttm)
9.06M
Revenue Growth
-51.99%
P/S Ratio
0.93
Revenue / Employee
109.20K
Employees
25
Market Cap
8.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 15.04M | -25.12M | -62.55% |
| Dec 31, 2022 | 40.15M | 20.07M | 99.93% |
| Dec 31, 2021 | 20.08M | 19.08M | 1,910.90% |
| Dec 31, 2020 | 998.73K | -38.87M | -97.50% |
| Dec 31, 2019 | 39.87M | 5.97M | 17.62% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.34B |
| Diagnostyka | 2.30B |
| Centrum Medyczne ENEL-MED | 820.59M |
| Synektik Spólka Akcyjna | 681.60M |
| Voxel | 568.83M |
| Selvita | 373.90M |
| Celon Pharma | 225.60M |
| Ryvu Therapeutics | 90.41M |